Edison Liu

Edison Liu is the President and CEO of the Jackson Laboratory, bringing his passion for personalized medicine to leading the development and utilization of complex mouse models for basic and translational research. Previously, he was the founding Executive Director of the Genome Institute of Singapore and served in similar capacities at the Singapore Cancer Syndicate and Singapore Tissue Network. Dr. Liu has won numerous awards for his work, most recently earning honors as Associate Member of the European Molecular Biology Organization (EMBO), Public Service Medal for controlling SARS in Singapore and an election to the board of directors at the American Association for Cancer Research. He is the President of the Human Genome Organisation (HUGO) and previously Chairman of the Health Sciences Authority in Singapore, among numerous other committees and advisory boards. Dr. Liu has authored more than 200 publications detailing his work on the involvement of kinases in cancer biology and molecular clinical epidemiology and functional genomics of human cancers. Dr. Liu earned his M.D. from Stanford University and was a resident at Barnes Hospital at Washington University, St. Louis.